World TB Day symposium in Paris
|
TBVI, together with with Calouste Gulbenkian Foundation, Fondation Mérieux, Friends of the Global Fund Europe and Stop TB Partnership organized a round table discussion and symposium in Paris on World TB Day, 24 March 2011:
Round table: The fight against tuberculosis: what’s new in research?
Symposium: Innovative funding and translation of discoveries into added value: new vaccines for TB
The programme of the meeting can be found here.
The press release about this event can be found here.
Here is an overview of the media outreach:
- Financial Times: New vaccines: A financial booster
- Science and Development Network: TB vaccines: getting them out of the lab
- Citizen News Service: Spotlight on new approach to tuberculosis vaccine funding
- Dutch Daily (Nederlands Dagblad): TBC: de moordenaar komt sterker terug
- Helsingin Sanomat, Opinion article by Juhani Eskola: Tuberkuloosi ei ole menneisyyden vitsaus (in Finnish)
- Opinion article by Peter Piot and John Bowis: Call for vaccine investment as LSHTM marks World TB Day
- Press statement by Helga Daub, German Parliamentarian of FPD: Tuberkulose greift wieder um sich (in German)
- Press release of German Social Democrats (SPD): SPD fordert neue Initiativen im Kampf gegen Tuberkulose (in German)
- Journalists against TB: Global health leaders discuss new approach to tuberculosis vaccine funding
- NU.nl, De Telegraaf, and several other Dutch newspapers and websites: Multiresistente tuberculose rukt op (in Dutch)
- Medical facts and several other Dutch newspapers and websites: Financiering cruciaal voor ontwikkeling van nieuwe tbc-vaccins (in Dutch)
- Tropika.net: Global health leaders discuss new approach to TB vaccine funding
Here is an overview of the presentations, as far available. Because the meeting was in Paris, some of them are only available in French:
- Ms Michèle Barzach, France, former Minister of health and President of ‘Friends of the Global Fund Europe: The needs of the world for innovative ways to combat Aids, Tuberculosis and Malaria.
- Mr Benoît Miribel, Director General Fondation Mérieux, France: ’Which innovative measures are needed to act more quickly against tuberculosis in the field?’ (in English)
- Dr. Onno Ruding, chairman of the Board of the Centre for European Policy Studies in Brussels., former minister of finances of The Netherlands: ‘TBVI as a model’ (in French)
- Dr. Joris Vandeputte, TBVI: ‘Translating science into products through innovative funding; developing tuberculosis vaccines’ (in French)
- Ms Clara de la Torre, Director of Research and Innovation within the Directorate General of Research, representing European commissioner for research, innovation and Science Geoghegan-Quinn: ‘The I-conomy’